World News: 12:30 GMT Thursday 29th August 2019. [TG Therapeutics, Inc. via Globe Newswire via SPi World News]
NEW YORK Aug 29 2019 GLOBE NEWSWIRE -- TG Therapeutics Inc NASDAQ TGTX todaythat abstracts featuring ublituximab the novel glycoengineered anti-CD20 monoclonal antibody in forms of multiple sclerosis (RMS) h...
Globe Newswire: 12:30 GMT Thursday 29th August 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.